Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 124 Records) |
| Query Trace: Glioblastoma and MGMT[original query] |
|---|
| Integrative analysis of CBR1 as a prognostic factor associated with IDH-mutant glioblastoma in the Chinese population. American journal of translational research 2022 9 14 (8): 5394-5408. Ji Pengxiang, Shan Xueshi, Wang Jian, Zhang Ping, Cai Zh |
| Brain radiotoxicity-related 15CAcBRT gene expression signature predicts survival prognosis of glioblastoma patients. Neuro-oncology 2022 Jul . Reyes-González Jesús, Barajas-Olmos Francisco, García-Ortiz Humberto, Magraner-Pardo Lorena, Pons Tirso, Moreno Sergio, Aguirre-Cruz Lucinda, Reyes-Abrahantes Andy, Martínez-Hernández Angélica, Contreras-Cubas Cecilia, Barrios-Payan Jorge, Ruiz-Garcia Henry, Hernandez-Pando Rogelio, Quiñones-Hinojosa Alfredo, Orozco Lorena, Abrahantes-Pérez María Del Carm |
| Clinical, histopathological, and molecular features of IDH-wildtype indolent diffuse glioma: comparison with typical glioblastoma. Journal of neuro-oncology 2022 7 159 (2): 397-408. Suzuki Hayato, Ono Takahiro, Koyota Souichi, Takahashi Masataka, Sugai Tamotsu, Nanjo Hiroshi, Shimizu Hiroa |
| [Impact of NGS results on patient outcome with a multiform glioblastoma]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 2022 6 26 (8): 987-993. Rom M, Schott R, Pencreac'h E, Cébula H, Cox D, Bender L, Antoni D, Lhermitte B, Noel |
| H3K27M-Altered Diffuse Midline Gliomas Among Adult Patients: A Systematic Review of Clinical Features and Survival Analysis. World neurosurgery 2022 6 165 e251-e264. Bin-Alamer Othman, Jimenez Adrian E, Azad Tej D, Bettegowda Chetan, Mukherjee Debr |
| HLA-G 14bp Ins/Del Polymorphism, Plasma Level of Soluble HLA-G, and Association with IL-6/IL-10 Ratio and Survival of Glioma Patients. Diagnostics (Basel, Switzerland) 2022 5 12 (5): . Bucova Maria, Kluckova Kristina, Kozak Jan, Rychly Boris, Suchankova Magda, Svajdler Marian, Matejcik Viktor, Steno Juraj, Zsemlye Eszter, Durmanova Vladimi |
| [Glioblastoma That Does Not Improve with Standard Treatment: Poor Prognostic Factors and Future Perspectives]. Brain and nerve = Shinkei kenkyu no shinpo 2022 5 74 (5): 668-676. Narita Yoshita |
| Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 4 28 (12): 2567-2578. Nayak Lakshmi, Standifer Nathan, Dietrich Jorg, Clarke Jennifer L, Dunn Gavin P, Lim Michael, Cloughesy Timothy, Gan Hui K, Flagg Elizabeth, George Elizabeth, Gaffey Sarah, Hayden Julia, Holcroft Christina, Wen Patrick Y, Macri Mary, Park Andrew J, Ricciardi Toni, Ryan Aileen, Schwarzenberger Paul, Venhaus Ralph, Reyes Melissa de Los, Durham Nicholas M, Creasy Todd, Huang Raymond Y, Kaley Thomas, Reardon David |
| Complete and Incomplete Resection for Progressive Glioblastoma Prolongs Post-Progression Survival. Frontiers in oncology 2022 3 12 755430. Behling Felix, Rang Julia, Dangel Elena, Noell Susan, Renovanz Mirjam, Mäurer Irina, Schittenhelm Jens, Bender Benjamin, Paulsen Frank, Brendel Bettina, Martus Peter, Gempt Jens, Barz Melanie, Meyer Bernhard, Tatagiba Marcos, Skardelly Mar |
| Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 3 28 (12): 2527-2535. Tesileanu C Mircea S, Sanson Marc, Wick Wolfgang, Brandes Alba A, Clement Paul M, Erridge Sara C, Vogelbaum Michael A, Nowak Anna K, Baurain Jean-Francois, Mason Warren P, Wheeler Helen, Chinot Olivier L, Gill Sanjeev, Griffin Matthew, Rogers Leland, Taal Walter, Rudà Roberta, Weller Michael, McBain Catherine, van Linde Myra E, Aldape Kenneth, Jenkins Robert B, Kros Johan M, Wesseling Pieter, von Deimling Andreas, Hoogstrate Youri, de Heer Iris, Atmodimedjo Peggy N, Dubbink Hendrikus J, Brouwer Rutger W W, van IJcken Wilfred F J, Cheung Kin Jip, Golfinopoulos Vassilis, Baumert Brigitta G, Gorlia Thierry, French Pim J, van den Bent Martin |
| Analytic approaches to clinical validation of results from preclinical models of glioblastoma: A systematic review. PloS one 2022 3 17 (3): e0264740. Fitt Beth, Loy Grace, Christopher Edward, Brennan Paul M, Poon Michael Tin Chu |
| The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study. Journal of neuro-oncology 2022 2 157 (1): 177-185. Ramos-Fresnedo Andres, Pullen Michael W, Perez-Vega Carlos, Domingo Ricardo A, Akinduro Oluwaseun O, Almeida Joao P, Suarez-Meade Paola, Marenco-Hillembrand Lina, Jentoft Mark E, Bendok Bernard R, Trifiletti Daniel M, Chaichana Kaisorn L, Porter Alyx B, Quiñones-Hinojosa Alfredo, Burns Terence C, Kizilbash Sani H, Middlebrooks Erik H, Sherman Wendy |
| Clinical Benefit of Bevacizumab and Irinotecan (BEV+IRI) in Patients With Relapsed/Refractory Glioblastoma (r/rGBM) and its Potential Predictors. Anticancer research 2022 12 42 (12): 6091-6098. Park Ji Hyun, Lee Hyun Seok, Choi Jin Woo, Lim So Dug, Koh Hyeon Kang, Cho Kyung Rae, Cho Joon, Koh Young-Cho, Yoon So You |
| Development of a novel glycolysis-related genes signature for isocitrate dehydrogenase 1-associated glioblastoma multiforme. Frontiers in immunology 2022 11 13 950917. Cai Xiaomin, Chen Zheng, Huang Caiquan, Shen Jie, Zeng Wenxian, Feng Shuang, Liu Yu, Li Shiting, Chen Mi |
| Preferential MGMT hypermethylation in SDH-deficient wild-type GIST. Journal of clinical pathology 2022 10 . Giger Olivier T, Ten Hoopen Rogier, Shorthouse David, Abdullahi Shukri, Bulusu Venkata Ramesh, Jadhav Saili, Maher Eamonn R, Casey Ruth |
| Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825. Neuro-oncology advances 2022 10 4 (1): vdac152. Scheurer Michael E, Zhou Renke, Gilbert Mark R, Bondy Melissa L, Sulman Erik P, Yuan Ying, Liu Yanhong, Vera Elizabeth, Wendland Merideth M, Youssef Emad F, Stieber Volker W, Komaki Ritsuko R, Flickinger John C, Kenyon Lawrence C, Robins H Ian, Hunter Grant K, Crocker Ian R, Chao Samuel T, Pugh Stephanie L, Armstrong Terri |
| Molecular landscape of IDH-wildtype, H3-wildtype glioblastomas of adolescents and young adults (AYA). Neuropathology and applied neurobiology 2022 Feb . Shi Zhi-Feng, Li Kay Ka-Wai, Huang Queenie Jun-Qi, Wang Wei-Wei, Kwan Johnny Sheung-Him, Chen Hong, Liu Xiang-Zhi, Li Wen-Cai, Chan Danny Tat-Ming, Zhang Zhen-Yu, Mao Ying, Ng Ho-Keu |
| Prognostic markers of DNA methylation and NGS sequencing in progressive glioblastoma from the EORTC-26101 trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 7 . Tobias Kessler, Daniel Schrimpf, Laura Doerner, Ling Hai, Leon D Kaulen, Jakob Ito, Martin van den Bent, Martin Taphoorn, Alba A Brandes, Ahmed Idbaih, Julien Dômont, Paul M Clement, Mario Campone, Martin Bendszus, Andreas von Deimling, Felix Sahm, Michael Platten, Wolfgang Wick, Antje Wi |
| Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma. Cancer immunology, immunotherapy : CII 2023 6 . Jun Takei, Yuko Kamata, Toshihide Tanaka, Nei Fukasawa, Kazutaka Gomisawa, Mari Satake, Ryosuke Mori, Yohei Yamamoto, Tomoya Suzuki, Ayaka Oda, Mutsunori Murahashi, Takahiro Fukuda, Masayuki Shimoda, Yuichi Murayama, Yasuharu Akasa |
| Racial and socioeconomic disparities in glioblastoma outcomes: A single-center, retrospective cohort study. Cancer 2023 5 . Dagoberto Estevez-Ordonez, Moaaz Abdelrashid, Elizabeth Coffee, Nicholas M B Laskay, Travis J Atchley, Rati Chkheidze, John B Fiveash, James M Markert, Mina Lobbous, Brandon M Maveal, Louis Burt Nabo |
| Prognostic role and interaction of TERT promoter status, telomere length and MGMT promoter methylation in newly diagnosed IDH wild-type glioblastoma patients. ESMO open 2023 5 8 (3): 101570. S Giunco, M Padovan, C Angelini, F Cavallin, G Cerretti, M Morello, M Caccese, B Rizzo, D d'Avella, A D Puppa, F Chioffi, P De Bonis, V Zagonel, A De Rossi, G Lombar |
| Identifying genetic variants regulating MGMT gene expression - A study in monozygotic Danish twins. Genomics 2023 3 110616. Mohammadnejad Afsaneh, Soerensen Mette, Mengel-From Jonas, Nygaard Marianne, Timofeeva Maria, He Liang, Clemmensen Signe Bedsted, Halekoh Ulrich, Dahlrot Rikke Hedegaard, Tan Qihua, Hjelmborg Jacob |
| Association of MGMT Promoter and Enhancer Methylation with Genetic Variants, Clinical Parameters, and Demographic Characteristics in Glioblastoma. Cancers 2023 12 15 (24): . Katja Zappe, Katharina Pühringer, Simon Pflug, Daniel Berger, Serge Weis, Sabine Spiegl-Kreinecker, Margit Cichna-Mar |
| Magnetic resonance-guided laser interstitial thermal therapy for recurrent glioblastoma and radiation necrosis: a single-surgeon case series. World neurosurgery 2023 11 . Jubran H Jubran, Lea Scherschinski, Nikhil Dholaria, Kelly A Shaftel, Dara S Farhadi, Femi C Oladokun, Benjamin K Hendricks, Kris A Smi |
| [Patients with long-term survival in malignant gliomas after photodynamic therapy]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2024 7 124 (6): 54-61. A Yu Rynda, V E Olyushin, D M Rostovtsev, K K Kukanov, S S Sklyar, Yu M Zabrodska |
| Immune cell infiltration and inflammatory landscape in primary brain tumours. Journal of translational medicine 2024 5 22 (1): 521. Amalia Luce, Marianna Abate, Giosuè Scognamiglio, Marco Montella, Domenico Iervolino, Severo Campione, Annabella Di Mauro, Orlando Sepe, Vincenzo Gigantino, Madhura S Tathode, Gerardo Ferrara, Roberto Monaco, Gianfranco De Dominicis, Gabriella Misso, Vittorio Gentile, Renato Franco, Silvia Zappavigna, Michele Caragl |
| Prognostic signature detects homologous recombination deficient in glioblastoma. Translational cancer research 2024 12 13 (11): 5883-5897. Dongdong Luo, Aiping Luo, Su Hu, Hailin Zhao, Xuefeng Yao, Dan Li, Biao Pe |
| CDKN2A Homozygous Deletion Is a Stronger Predictor of Outcome than IDH1/2-Mutation in CNS WHO Grade 4 Gliomas. Biomedicines 2024 10 12 (10): . Sang Hyuk Lee, Tae Gyu Kim, Kyeong Hwa Ryu, Seok Hyun Kim, Young Zoon K |
| De Ritis ratio in elderly glioblastoma patients treated with chemoradiation: A comprehensive analysis of serum biomarkers. Neuro-oncology advances 2024 1 6 (1): vdad173. Jina Kim, Hye In Lee, In Ah Kim, Joo Ho Lee, Jaeho Cho, Chan Woo Wee, Hong In Yo |
| Prognostic factors for overall survival in elderly patients with glioblastoma: Analysis of the pooled NOA-08 and Nordic trials with the CCTG-EORTC (CE.6) trial. Neuro-oncology advances 2025 1 6 (1): vdae211. Annika Malmström, Felix B Oppong, Christopher J O Callaghan, Wolfgang Wick, Normand Laperriere, Thierry Gorlia, Michael Weller, Roger Henriksson, Warren Mason, Michael Platten, Eva Cantagallo, Bjørn H Grønberg, Guido Reifenberger, Christine Marosi, James R Perry, |
- Page last reviewed:Feb 1, 2024
- Content source: